Adverse effects of anthracyclines: does atorvastatin STOP-CArdiotoxicity?

Affiliations

¹ Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, Rome 00168, Italy.
² Department of Pharmacology, Catholic University of the Sacred Heart, Rome, Italy.

Comment

Daniela Pedicino et al. Eur Heart J. 2023.

. 2023 Nov 14;44(43):4506-4507.

doi: 10.1093/eurheartj/ehad611.

¹ Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemelli 8, Rome 00168, Italy.
² Department of Pharmacology, Catholic University of the Sacred Heart, Rome, Italy.

No abstract available

Comment on

Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
Neilan TG, Quinaglia T, Onoue T, Mahmood SS, Drobni ZD, Gilman HK, Smith A, Heemelaar JC, Brahmbhatt P, Ho JS, Sama S, Svoboda J, Neuberg DS, Abramson JS, Hochberg EP, Barnes JA, Armand P, Jacobsen ED, Jacobson CA, Kim AI, Soumerai JD, Han Y, Friedman RS, Lacasce AS, Ky B, Landsburg D, Nasta S, Kwong RY, Jerosch-Herold M, Redd RA, Hua L, Januzzi JL, Asnani A, Mousavi N, Scherrer-Crosbie M. Neilan TG, et al. JAMA. 2023 Aug 8;330(6):528-536. doi: 10.1001/jama.2023.11887. JAMA. 2023. PMID: 37552303 Free PMC article. Clinical Trial.